Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Massard

Showing results (11-20 of 364) with videos related to

Pageof 37
Sort By:
La Revue Du Praticien|March 13, 2010
[Prostate tumors]Christophe Massard, Karim Fizazi
Bulletin Du Cancer|May 30, 2015
[New therapies in metastatic castration resistant prostate cancer]Constance Thibault, Christophe Massard
The Lancet. Respiratory Medicine|April 20, 2019
Exploring the optimal use of alectinibDiego Enrico, Christophe Massard, Benjamin Besse
JAMA Oncology|April 1, 2021
Patient Willingness to Enroll in Cancer Clinical Trials When Sites Return to Prepandemic StatusArnaud Bayle, Fabrice Barlesi, Christophe Massard
European Urology|April 17, 2014
One size does not fit all: can we choose the best sequence of treatment in asymptomatic castration-resistant prostate cancer patients?Yohann Loriot, Christophe Massard, Karim Fizazi
JAMA Oncology|November 2, 2018
Focus on the Number of Radiation Oncology Trials or on Clinical Relevance?Cyrus Chargari, Christophe Massard, Eric Deutsch
Bulletin Du Cancer|February 27, 2017
[Immunotherapy for the treatment of patients with genitourinary cancers: Review and perspectives]Frédéric Bigot, Clément Bonnet, Christophe Massard
Bulletin Du Cancer|April 24, 2007
[Intraperitoneal chemotherapy in first-line combination treatment for advanced ovarian cancer]Christophe Massard, Catherine Lhommé, Patricia Pautier
Nature Reviews. Clinical Oncology|November 4, 2011
Carcinomas of an unknown primary origin--diagnosis and treatmentChristophe Massard, Yohann Loriot, Karim Fizazi
Bulletin Du Cancer|October 26, 2013
[Bone targeted therapies: new agents]Claire Barth, Christophe Massard, Stéphane Vignot
Pageof 37

Showing results (11-20 of 364) with videos related to

Sort By:
Pageof 37
La Revue Du Praticien|March 13, 2010
[Prostate tumors]Christophe Massard, Karim Fizazi
Bulletin Du Cancer|May 30, 2015
[New therapies in metastatic castration resistant prostate cancer]Constance Thibault, Christophe Massard
The Lancet. Respiratory Medicine|April 20, 2019
Exploring the optimal use of alectinibDiego Enrico, Christophe Massard, Benjamin Besse
JAMA Oncology|April 1, 2021
Patient Willingness to Enroll in Cancer Clinical Trials When Sites Return to Prepandemic StatusArnaud Bayle, Fabrice Barlesi, Christophe Massard
European Urology|April 17, 2014
One size does not fit all: can we choose the best sequence of treatment in asymptomatic castration-resistant prostate cancer patients?Yohann Loriot, Christophe Massard, Karim Fizazi
JAMA Oncology|November 2, 2018
Focus on the Number of Radiation Oncology Trials or on Clinical Relevance?Cyrus Chargari, Christophe Massard, Eric Deutsch
Bulletin Du Cancer|February 27, 2017
[Immunotherapy for the treatment of patients with genitourinary cancers: Review and perspectives]Frédéric Bigot, Clément Bonnet, Christophe Massard
Bulletin Du Cancer|April 24, 2007
[Intraperitoneal chemotherapy in first-line combination treatment for advanced ovarian cancer]Christophe Massard, Catherine Lhommé, Patricia Pautier
Nature Reviews. Clinical Oncology|November 4, 2011
Carcinomas of an unknown primary origin--diagnosis and treatmentChristophe Massard, Yohann Loriot, Karim Fizazi
Bulletin Du Cancer|October 26, 2013
[Bone targeted therapies: new agents]Claire Barth, Christophe Massard, Stéphane Vignot
Pageof 37